drugset
drugset / Trial / NCT03542851

A Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia

NCT03542851 ↗

Phase 2 Unknown 80 enrolled Balance Therapeutics
RandomizedCrossoverSingle-blindTreatment

Summary

This is a randomized, placebo-controlled, double-blind, crossover study of oral BTD-001 in adults with Idiopathic Hypersomnia.

Timeline

Start
2018-05-29
Primary completion
2020-05-01
Completion
2020-05-28

Drugs

EvaluationDrugModalityDoseRoute
Subject PENTYLENETETRAZOL Small molecule — Oral

Indications

idiopathic hypersomnia